Literature DB >> 32157963

[Diagnosis and Therapy of Acute Myeloid Leukemia].

Michael Medinger1, Dominik Heim1, Jörg P Halter1, Claudia Lengerke1, Jakob R Passweg1.   

Abstract

Diagnosis and Therapy of Acute Myeloid Leukemia Abstract. Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically heterogeneous disease, and its incidence is increasing as the population ages. Cytogenetic anomalies and mutation testing remain important prognostic tools for tailoring treatment after induction therapy. Despite major advances in understanding the genetic landscape of AML and its impact on the pathophysiology and biology of the disease, as well as the rapid development of new drugs, standard treatment options have not experienced major changes during the past three decades. Allogeneic hematopoietic stem cell transplantation (HSCT) remains the best chance for cure. Here we review diagnosis and therapy of AML.

Entities:  

Year:  2019        PMID: 32157963     DOI: 10.1024/0040-5930/a001126

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  5 in total

1.  Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission.

Authors:  Qiang Zeng; Zhigang Liu; Bing Xiang
Journal:  Ann Hematol       Date:  2022-05-16       Impact factor: 4.030

2.  Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.

Authors:  Sharareh Siamakpour-Reihani; Felicia Cao; Jing Lyu; Yi Ren; Andrew B Nixon; Jichun Xie; Amy T Bush; Mark D Starr; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Virginia Byers Kraus; Janet L Huebner; Nelson J Chao; Anthony D Sung
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

3.  A systematic review and meta-analysis on the risk factors of acute myeloid leukemia.

Authors:  Yanrong Guo; Wenwen Wang; Huali Sun
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

4.  MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.

Authors:  Jiajia Li; Yanping Wu; Meng Wang; Xiaofeng Chen; Zhongyu Li; Xue Bai; Haotian Wu
Journal:  Comput Math Methods Med       Date:  2022-09-07       Impact factor: 2.809

5.  lncRNA GAS5 Induces Cell Apoptosis in Acute Myeloid Leukemia by Targeting Nrf2.

Authors:  Xiaohua Qin; Yanling Jiang; Xiaojun Zhang; Dan Li
Journal:  Dis Markers       Date:  2022-08-24       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.